Ko Suzuki

2.8k total citations · 1 hit paper
41 papers, 2.3k citations indexed

About

Ko Suzuki is a scholar working on Cancer Research, Hematology and Molecular Biology. According to data from OpenAlex, Ko Suzuki has authored 41 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Ko Suzuki's work include Protease and Inhibitor Mechanisms (11 papers), Blood transfusion and management (6 papers) and Peptidase Inhibition and Analysis (6 papers). Ko Suzuki is often cited by papers focused on Protease and Inhibitor Mechanisms (11 papers), Blood transfusion and management (6 papers) and Peptidase Inhibition and Analysis (6 papers). Ko Suzuki collaborates with scholars based in Japan, United States and United Kingdom. Ko Suzuki's co-authors include Hideaki Nagase, Masuko Suzuki, Shigeo Suzuki, Akio Tokoro, Yoshio Okawa, Guy S. Salvesen, Jan J. Enghild, Takeshi Mikami, T. Morodomi and Yasunori Okada and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biochemistry.

In The Last Decade

Ko Suzuki

40 papers receiving 2.2k citations

Hit Papers

Antitumor effect of hexa-N-acetylchitohexaose and chitohe... 1986 2026 1999 2012 1986 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ko Suzuki Japan 23 772 707 443 413 327 41 2.3k
Jacek Kijowski Poland 24 1.5k 2.0× 561 0.8× 483 1.1× 101 0.2× 453 1.4× 112 3.0k
Nieves Olmo Spain 26 1000 1.3× 201 0.3× 362 0.8× 325 0.8× 75 0.2× 69 2.3k
Marta L. Corcoran United States 21 765 1.0× 968 1.4× 706 1.6× 78 0.2× 271 0.8× 27 2.5k
Takahisa Imamura Japan 34 844 1.1× 354 0.5× 391 0.9× 83 0.2× 400 1.2× 104 3.5k
David J. Etherington United Kingdom 26 863 1.1× 604 0.9× 251 0.6× 186 0.5× 98 0.3× 59 2.3k
Javier Turnay Spain 28 1.6k 2.1× 236 0.3× 406 0.9× 956 2.3× 76 0.2× 68 3.2k
Ulrich Eckhard Canada 25 1.0k 1.3× 318 0.4× 390 0.9× 195 0.5× 96 0.3× 49 2.4k
N.S. Ramamurthy United States 26 573 0.7× 623 0.9× 447 1.0× 61 0.1× 172 0.5× 55 2.9k
Paul C. Billings United States 39 1.9k 2.5× 518 0.7× 537 1.2× 77 0.2× 230 0.7× 96 3.8k
Zeenat Gunja‐Smith United States 22 562 0.7× 527 0.7× 416 0.9× 57 0.1× 109 0.3× 31 2.1k

Countries citing papers authored by Ko Suzuki

Since Specialization
Citations

This map shows the geographic impact of Ko Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ko Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ko Suzuki more than expected).

Fields of papers citing papers by Ko Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ko Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ko Suzuki. The network helps show where Ko Suzuki may publish in the future.

Co-authorship network of co-authors of Ko Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Ko Suzuki. A scholar is included among the top collaborators of Ko Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ko Suzuki. Ko Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Yoshikawa, Akira, Yoshiharu Suzuki, Masako Tanaka, et al.. (2009). Age‐ and gender‐specific distributions of hepatitis B virus (HBV) genotypes in Japanese HBV‐positive blood donors. Transfusion. 49(7). 1314–1320. 16 indexed citations
4.
Masu, Kazuya, I Ohno, Ko Suzuki, et al.. (2002). Proliferative effects of eosinophil lysates on cultured human airway smooth muscle cells. Clinical & Experimental Allergy. 32(4). 595–601. 8 indexed citations
5.
Suzuki, Ko, et al.. (2001). Comparison of platelet quality in washed platelet concentrates prepared with different synthetics storage solutions.. Journal of the Japan Society of Blood Transfusion. 47(5). 777–782. 2 indexed citations
6.
Ohno, Isao, Shinji Okada, Yuichi Ohkawara, et al.. (1999). Inhibition of Matrix Metalloproteinases Prevents Allergen-Induced Airway Inflammation in a Murine Model of Asthma. The Journal of Immunology. 162(7). 4212–4219. 186 indexed citations
7.
Netzer, Kai‐Olaf, Ko Suzuki, Yoshifumi Itoh, Billy G. Hudson, & Raja G. Khalifah. (1998). Comparative analysis of the noncollagenous NC1 domain of type IV collagen: Identification of structural features important for assembly, function, and pathogenesis. Protein Science. 7(6). 1340–1351. 38 indexed citations
8.
Arumugam, Sengodagounder, Christopher L. Hemme, Naoki Yoshida, et al.. (1998). TIMP-1 Contact Sites and Perturbations of Stromelysin 1 Mapped by NMR and a Paramagnetic Surface Probe. Biochemistry. 37(27). 9650–9657. 34 indexed citations
9.
Nagase, Hideaki, Ko Suzuki, Tim E. Cawston, & Keith Brew. (1997). Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1). Biochemical Journal. 325(1). 163–167. 38 indexed citations
10.
Sharma, Ram, Ko Suzuki, Hideaki Nagase, & Virginia J. Savin. (1996). Matrix metalloproteinase (stromelysin-1) increases the albumin permeability of isolated rat glomeruli. Journal of Laboratory and Clinical Medicine. 128(3). 297–303. 30 indexed citations
11.
12.
Suzuki, Ko, et al.. (1993). Development to the Blastocyst Stage of Pig Embryos Cultured in the Amniotic Fluid of Developing Chick Embryos.. Journal of Veterinary Medical Science. 55(5). 889–891. 6 indexed citations
13.
Sasaguri, Yasuyuki, Setsuro Komiya, Kazushige Sugama, et al.. (1992). Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumor of bone.. PubMed. 141(3). 611–21. 44 indexed citations
15.
Okada, Yasunori, T. Morodomi, Jan J. Enghild, et al.. (1990). Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. European Journal of Biochemistry. 194(3). 721–730. 377 indexed citations
16.
Bejarano, P.A., Milton E. Noelken, Ko Suzuki, Billy G. Hudson, & Hideaki Nagase. (1988). Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin). Biochemical Journal. 256(2). 413–419. 58 indexed citations
17.
Suzuki, Ko, Yoshio Okawa, Shigeo Suzuki, & Masuko Suzuki. (1987). Candidacidal Effect of Peritoneal Exudate Cells in Mice Administered with Chitin or Chitosan. Microbiology and Immunology. 31(4). 375–379. 22 indexed citations
18.
Okawa, Yoshio, et al.. (1985). Protective effect of acidic mannan fraction of bakers' yeast against Staphylococcus aureus infection in mice.. Journal of Pharmacobio-Dynamics. 8(11). 942–947. 2 indexed citations
19.
Okawa, Yoshio, Kazuhiko Hashimoto, Ko Suzuki, Shigeo Suzuki, & Masuko Suzuki. (1984). Antitumor activity of cell wall from Streptoverticillium cinnamoneum.. Chemical and Pharmaceutical Bulletin. 32(2). 786–790. 1 indexed citations
20.
Hashimoto, Kazuhiko, et al.. (1983). Antitumor activity of acidic mannan fraction from bakers' yeast.. Journal of Pharmacobio-Dynamics. 6(9). 668–676. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026